The US Antibody Drug Conjugate Market is a key engine of innovation in targeted oncology, where ADCs combine tumor‑specific antibodies with highly potent cytotoxic payloads. US Antibody Drug Conjugate Market Next‑generation ADC design Manufacturers are refining linkers, payloads, and antibody‑specificity to improve therapeutic‑index and reduce off‑target toxicity. This is...